Tissue Regenix Group (LON:TRX) Shares Pass Above 50 Day Moving Average – Here’s Why

Tissue Regenix Group plc (LON:TRX) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 58.20 ($0.73) and traded as high as GBX 60 ($0.75). Tissue Regenix Group shares last traded at GBX 60 ($0.75), with a volume of 12,966 shares trading hands.

Tissue Regenix Group Stock Down 0.3 %

The firm’s fifty day moving average is GBX 58.20 and its two-hundred day moving average is GBX 60.78. The firm has a market cap of £41.46 million, a price-to-earnings ratio of -5,820.00 and a beta of 1.61. The company has a debt-to-equity ratio of 35.69, a current ratio of 3.74 and a quick ratio of 2.36.

Tissue Regenix Group Company Profile

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.